-
Alex Kentsis
- Jun 05, 2014
Paolo Cifani is selected as American-Italian Cancer Foundation Fellow
Congratulations to Paolo for being selected as American-Italian Cancer Foundation Fellow! For more than 30 years, AICF has supported both improved patient care and innovative cancer research, and we are grateful for their recognition and support of Paolo’s work.
Twitter Feed
Load More...Congratulations to Nai-Kong Cheung and many colleagues on this landmark approval, a target and antibody discovered and developed by decades of research @sloan_kettering #MSKKids https://www.globenewswire.com/news-release/2020/11/25/2134120/0/en/FDA-Approves-Y-mAbs-DANYELZA-naxitamab-gqgk-for-the-Treatment-of-Neuroblastoma.html
Interested in pursuing a PhD in pharmacology? Check out the link to learn more about our program @WeillCornellGS
https://youtu.be/G_TzHbrvnU0Another fascinating paper from Tim Coorens, Sam Behjati and colleagues on developmental origins of predisposed neuroblastoma: https://www.nejm.org/doi/full/10.1056/NEJMoa2000962
The new NCI’s #CPTAC and @CBTNetwork pediatric brain cancer study released today in @CellCellPress provides an excellent source of #proteogenomic data for the NCI’s Childhood Cancer Data Initiative. Read more: https://www.cell.com/cell/fulltext/S0092-8674(20)31451-3 @IcahnMountSinai @theNCI @CHOP @ChildrensNatl
Please watch @paolocifani explain his research on the Quantitative Cancer Proteomics Atlas https://youtu.be/d3_Rph7ERgU
